Your browser doesn't support javascript.
loading
Body weight and return to work among survivors of early-stage breast cancer.
Di Meglio, Antonio; Menvielle, Gwenn; Dumas, Agnes; Gbenou, Arnauld; Pinto, Sandrine; Bovagnet, Thomas; Martin, Elise; Ferreira, Arlindo R; Vanlemmens, Laurence; Arsene, Olivier; Ibrahim, Mahmoud; Wassermann, Johanna; Martin, Anne Laure; Lemonnier, Jerome; Del Mastro, Lucia; Jones, Lee W; Partridge, Ann H; Ligibel, Jennifer A; Andre, Fabrice; Michiels, Stefan; Vaz Luis, Ines.
Afiliação
  • Di Meglio A; Prédicteurs moléculaires et nouvelles cibles en oncologie, INSERM Unit 981, Gustave Roussy, Villejuif, France.
  • Menvielle G; Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Dumas A; INSERM Unit 1018, Villejuif, France; UMR Unit 1123, Paris, France; Université Paris Diderot UFR de Médecine, Paris, France.
  • Gbenou A; Prédicteurs moléculaires et nouvelles cibles en oncologie, INSERM Unit 981, Gustave Roussy, Villejuif, France.
  • Pinto S; Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Bovagnet T; Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Martin E; Prédicteurs moléculaires et nouvelles cibles en oncologie, INSERM Unit 981, Gustave Roussy, Villejuif, France.
  • Ferreira AR; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisboa, Portugal.
  • Vanlemmens L; Oscar Lambret Cancer Centre, Lille, France.
  • Arsene O; Centre Hospitalier de Blois, Blois, France.
  • Ibrahim M; Regional Hospital Centre Orleans Porte Madeleine Hospital, Orleans, France.
  • Wassermann J; Hopital Universitaire Pitie Salpetriere, Paris, France.
  • Martin AL; UNICANCER, Paris, France.
  • Lemonnier J; UNICANCER, Paris, France.
  • Del Mastro L; Ospedale Policlinico San Martino Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Genova, Italy.
  • Jones LW; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Partridge AH; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Ligibel JA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Andre F; Prédicteurs moléculaires et nouvelles cibles en oncologie, INSERM Unit 981, Gustave Roussy, Villejuif, France; University Paris-Saclay, Villejuif, France.
  • Michiels S; University Paris-Saclay, Villejuif, France; Department of biostatistics and epidemiology, Gustave Roussy Cancer Campus, Villejuif, France; Oncostat Inserm U1018, Villejuif, France.
  • Vaz Luis I; Prédicteurs moléculaires et nouvelles cibles en oncologie, INSERM Unit 981, Gustave Roussy, Villejuif, France; Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: INES-MARIA.VAZ-DUARTE-LUIS@gustaveroussy.fr.
ESMO Open ; 5(6): e000908, 2020 11.
Article em En | MEDLINE | ID: mdl-33172957
ABSTRACT

BACKGROUND:

Many breast cancer (BC) survivors are employed at diagnosis and are expected to return to work after treatment. Among them, around 50% are overweight or obese. There are limited data about the impact of body weight on their ability to return to work.

METHODS:

We used data from CANcer TOxicity (NCT01993498), a prospective, multicentre cohort of women with stage I-III BC. Professionally active women who were ≥5 years younger than retirement age were identified. Multivariable logistic regression models examined associations of body mass index (BMI) at diagnosis and subsequent weight changes with non-return to work 2 years after diagnosis, adjusting for psychosocial, treatment and behavioural characteristics.

RESULTS:

Among 1869 women, 689 were overweight or obese. Overall, 398 patients (21.3%) had not returned to work 2 years after diagnosis. Non-return to work was more likely for overweight or obese than underweight or normal weight patients (adjusted OR (aOR) 1.32; 95% CI, 1.01 to 1.75; p=0.045). Weight loss (≥5%) was observed in 15.7% overweight or obese and 8.7% underweight or normal weight patients and was associated with significant increases in physical activity only among overweight or obese patients (mean change, +4.7 metabolic-equivalent-of-task-hour/week; 95% CI +1.9 to +7.5). Overweight or obese patients who lost weight were more likely to return to work compared with those who did not lose weight (aOR of non-return-to-work, 0.48; 95% CI 0.24 to 0.97, p=0.0418), whereas weight loss was associated with increased odds of non-return to work among underweight or normal weight women (aOR 2.07; 95% CI 1.20 to 3.56, p=0.0086) (pinteractionBMI×weight changes=0.0002). The continuous trend of weight gain on non-return to work was significant for overweight or obese patients (aOR for one-percent-unit difference, 1.03; 95% CI 1.01 to 1.06, p=0.030).

CONCLUSIONS:

Excess weight may be a barrier to return to work. Among overweight or obese BC survivors, weight loss was associated with higher rates of return to work, whereas further weight gain was associated with lower likelihood of return to work. Employment outcomes should be evaluated in randomised studies of weight management.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article